8-Oxa-2-aza-spiro[4.5]decane oxalate
95%
- Product Code: 75749
CAS:
1408075-68-2
Molecular Weight: | 231.25 g./mol | Molecular Formula: | C₁₀H₁₇NO₅ |
---|---|---|---|
EC Number: | MDL Number: | MFCD23106140 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the pharmaceutical and chemical research sectors. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its spirocyclic structure makes it a valuable scaffold for developing compounds with potential therapeutic effects, such as modulators of neurotransmitter systems. Additionally, it is employed in organic synthesis to create complex molecular architectures, aiding in the exploration of new drug candidates and chemical entities.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
1.000 | 10-20 days | ฿4,830.00 |
+
-
|
5.000 | 10-20 days | ฿18,590.00 |
+
-
|
8-Oxa-2-aza-spiro[4.5]decane oxalate
This compound is primarily utilized in the pharmaceutical and chemical research sectors. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its spirocyclic structure makes it a valuable scaffold for developing compounds with potential therapeutic effects, such as modulators of neurotransmitter systems. Additionally, it is employed in organic synthesis to create complex molecular architectures, aiding in the exploration of new drug candidates and chemical entities.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :